HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Neuropeptide SF (human)

HCID 54557339
New reaction
Print
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
192387-39-6
Standard SMILES
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
InChIKey
ZOCAYXQBGJIAOK-UDXVSVLKSA-N
Molecular formula
C65H94N18O15
Average molar mass
1,367.6 g/mol
Monoisotopic mass
1,366.71460436

Names & identifiers

Preferred name
Neuropeptide SF (human)
IUPAC
(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide
English name
NEUROPEPTIDE SF (HUMAN)
Molecular formula
C65H94N18O15
Molecular weight
1367.55

Names & synonyms

Neuropeptide SF (human)192387-39-6Neuropeptide SF (human) trifluoroacetate salt H-Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 trifluoroacetate saltH-SQAFLFQPQRF-NH2Neuropeptide SF (human) trifluoroacetate saltH-Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2orb1693321CHEMBL3360826DTXSID00712191HY-P1245AKOS024456830FN109418
Show more names
Neuropeptide SF human >=92% (HPLC), solidNeuropeptide SF(human 11-amino acid fragment)Dalargin(wound healing peptide: Afonskaya N.I. Bull.Exp.Biol.Med. 12, 754, 1986)L-Phenylalaninamide, L-seryl-L-glutaminyl-L-alanyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-glutaminyl-L-arginyl-
MS-33169CS-0029114T36926L-Seryl-L-glutaminyl-L-alanyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-glutaminyl-N~5~-(diaminomethylidene)-L-ornithyl-L-phenylalaninamide

Properties

Computed structural properties

XLogP
-3.2
Topological polar surface area
565 Ų
Hydrogen bond donors
17
Hydrogen bond acceptors
17
Rotatable bonds
42
Heavy atoms
98
Formal charge
0
Complexity
2,750

Physicochemical properties

Density
1.43 · 1.43±0.1 g/cm3(Predicted)
storage temp.
20 °C · −20°C
form
solid
pka
12.03 · 12.03±0.10(Predicted)
color
White to off-white
Water Solubility
1 mg/ml · Soluble to 1 mg/ml in 10% acetonitrile / sterile water
Sequence
2 · Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2
Comptox DTXSID
712191 · DTXSID00712191
WGK Germany
3 · 3

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3

Chemistry & industry

Applications · 1 item

UsesNeuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH[1].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
192387-39-6
PubChem CID
54557339
DTXSID
DTXSID00712191
ChEMBL
CHEMBL3360826
Nikkaji
J862.463A